Malaysian Genomics collaborates with South Korean healthcare provider

KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd's wholly-owned subsidiary MGRC Therapeutics Sdn Bhd has entered into a collaboration with South Korea-listed Dx&Vx Co Ltd to drive the development and supply of advanced genomic testing services.

It said MGRC Therapeutics will leverage its extensive expertise in genomics and biopharmaceuticals to support the operational and technical aspects of the genomic testing services.

Uh-oh! Daily quota reached.


Experience an ad-free unlimited reading on both web and app.

Subscribe 
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Malaysian Genomics , MGRC , biopharmaceutical , genomics , DxVx

   

Report it to us.

Next In Business News
Malaysia's private non-financial sector's credit growth moderated to 4.8% in September
US tariffs on China to have mixed impact on Asean economies - OCBC
Minox International proposes 1-for-2 bonus issue of warrants
UBS posts bigger-than-expected net profit in third quarter
China and Hong Kong stocks drop as US election risks loom
StanChart third-quarter profit more than doubles on strong wealth growth, raises guidance
Bursa Malaysia's net profit jumps 42% to RM85.74mil in 3Q as ADV climbs
FBM KLCI slides as US election jitters mount
Australian dollar stuck near three-month lows on mixed inflation data
Axis-REIT raises RM449.73mil from private placement

Trending in Business

Others Also Read

Load more

Copyright © 1995- Star Media Group Berhad [197101000523 (10894-D)]

Best viewed on Chrome browsers.